Report Categories
View AllRecent Articles
View All
VRCA Verrica Pharmaceuticals reports narrower than expected Q4 2025 loss with shares slipping 157 in regular trading
How NexMetals NEXM is positioning for the next five years Buying Pressure 20260506
What failed trades Xilio Therapeutics XLO Slight Gain 20260427
How IperionX IPX performance compares to expectations Buying Pressure 20260505